Clinnova European Consortium

Clinnova’s mission is to drive the digitalisation of healthcare and advance precision medicine by building a robust, data-enabling environment. The aim is to make high-quality, interoperable health data accessible, shareable, and ready for meaningful analysis, ultimately improving patient care and accelerating biomedical research through patient-oriented applications. Clinnova focuses on three major use cases of chronic diseases: Multiple Sclerosis (MS), Inflammatory Bowel Disease (IBD), and Rheumatoid Arthritis( RA), showcasing the potential of its platform in diverse clinical contexts.

By establishing a high-performance, interoperable data infrastructure, Clinnova aspires to catalyse the emergence of a vibrant digital health industry in the region, laying the groundwork for a European development platform. We are actively exploring public and private investment opportunities to attract start-ups and solution providers into this growing ecosystem. Together, these efforts create the conditions, momentum, and opportunity for a European digital health industry to achieve international leadership.

Rheumatoid Arthritis
(RA)

Multiple Sclerosis
(MS)

Inflammatory Bowel Diseases (IBD)

January 2024, over 70 collaborators came together in Strasbourg for the consortium meeting, marking a milestone in our shared journey. The next gathering is already on the horizon, expected in October 2025, a testament to the Clinnova collective ambition shaping the future of healthcare.
© RC2NB 2025
crossmenuchevron-down